Peter J. Nestor

Peter J. Nestor

Auto-generated profile, based on publicly available information

Peter J. Nestor

Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute The University of Queensland St Lucia Queensland Australia

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2007 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
KPKaralyn Patterson
Karalyn Patterson
PNPeter J. Nestor
Peter J. Nestor
TRTimothy T. Rogers
Timothy T. Rogers

3 May 2017 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
GHGünter U. Höglinger
Günter U. Höglinger
GRGesine Respondek
Gesine Respondek
MSMaria Stamelou
Maria Stamelou
CKCarolin Kurz
Carolin Kurz
KJKeith A. Josephs
Keith A. Josephs
FGfor the Movement Disorder Society–endorsed PSP Study Group
for the Movement Disorder Society–endorsed PSP Study Group

1 March 2017 in Alzheimer's & Dementia
Verified
Journal Article
Open access
SCSebastian Crutch
Sebastian Crutch
JSJonathan M. Schott
Jonathan M. Schott
GRGil D. Rabinovici
Gil D. Rabinovici
MMMelissa E. Murray
Melissa E. Murray
JSJulie S. Snowden
Julie S. Snowden
AAAlzheimer's Association ISTAART Atypical Alzheimer's Disease and Associated Syndromes Professional Interest Area
Alzheimer's Association ISTAART Atypical Alzheimer's Disease and Associated Syndromes Professional Interest Area
Introduction: A classification framework for posterior cortical atrophy (PCA) is proposed to improve the uniformity of definition of the syndrome in a variety of research settings.Methods: Consensus statements about PCA were developed through a detailed literature review, the formation of an international multidisciplinary working party which convened on four occasions, and a Web‐based quantitative survey regarding symptom frequency and the conceptualization of PCA.Results: A three‐level classification framework for PCA is described comprising both syndrome‐ and disease‐level descriptions. Classification level 1 (PCA) defines the core clinical, cognitive, and neuroimaging features and exclusion criteria of the clinico‐radiological syndrome. Classification level 2 (PCA‐pure, PCA‐plus) establishes whether, in addition to the core PCA syndrome, the core features of any other neurodegenerative syndromes are present. Classification level 3 (PCA attributable to AD [PCA‐AD], Lewy body disease [PCA‐LBD], corticobasal degeneration [PCA‐CBD], prion disease [PCA‐prion]) provides a more formal determination of the underlying cause of the PCA syndrome, based on available pathophysiological biomarker evidence. The issue of additional syndrome‐level descriptors is discussed in relation to the challenges of defining stages of syndrome severity and characterizing phenotypic heterogeneity within the PCA spectrum.Discussion: There was strong agreement regarding the definition of the core clinico‐radiological syndrome, meaning that the current consensus statement should be regarded as a refinement, development, and extension of previous single‐center PCA criteria rather than any wholesale alteration or redescription of the syndrome. The framework and terminology may facilitate the interpretation of research data across studies, be applicable across a broad range of research scenarios (e.g., behavioral interventions, pharmacological trials), and provide a foundation for future collaborative work.

1 October 2007 in Brain
Verified
Journal Article
Open access
PDF file
SAS. Alladi
S. Alladi
JXJ. Xuereb
J. Xuereb
TBT. Bak
T. Bak
PNP. Nestor
P. Nestor
JKJ. Knibb
J. Knibb
JHJ. R. Hodges
J. R. Hodges
To determine the frequency of Alzheimer's disease (AD) pathology in patients presenting with progressive focal cortical syndromes, notably posterior cortical atrophy (PCA), corticobasal syndrome (CBS), behavioural variant frontotemporal dementia (bvFTD), progressive non-fluent aphasia (PNFA) (or a mixed aphasia) and semantic dementia (SD); and to compare the age of onset, evolution and prognosis in patients with focal cortical presentations of AD versus more typical AD and those with non AD pathology. From a total of 200 patients with comprehensive prospective clinical and pathological data we selected 120 : 100 consecutive cases with focal cortical syndromes and 20 with clinically typical AD. Clinical files were reviewed blind to pathological diagnosis. Of the 100 patients with focal syndromes, 34 had AD as the primary pathological diagnosis with the following distribution across clinical subtypes: all 7 of the PCA (100%); 6 of 12 with CBS (50%); 2 of 28 with bvFTD (7.1%); 12 of 26 with PNFA (44.1%); 5 of 7 with mixed aphasia (71.4%) and 2 of 20 with SD (10%). Of 20 with clinically typical AD, 19 had pathological AD. Age at both onset and death was greater in the atypical AD cases than those with non-AD pathology, although survival was equivalent. AD is a much commoner cause of focal cortical syndromes than previously recognised, particularly in PCA, PNFA and CBS, but rarely causes SD or bvFTD. The focal syndrome may remain pure for many years. Patients with atypical AD tend to be older than those with non-AD pathology.

1 July 2004 in Nature Medicine
Verified
Journal Article
Closed access
PNPeter J Nestor
Peter J Nestor
PSPhilip Scheltens
Philip Scheltens
JHJohn R Hodges
John R Hodges

15 October 2010 in Brain
Verified
Journal Article
Closed access
PDF file
Marco MionMarco Mion
Marco Mion
KPKaralyn Patterson
Karalyn Patterson
JAJulio Acosta-Cabronero
Julio Acosta-Cabronero
GPGeorge Pengas
George Pengas
DGDavid Izquierdo Garcia
David Izquierdo Garcia
PNPeter J. Nestor
Peter J. Nestor
The study of patients with semantic dementia, a variant of frontotemporal lobar degeneration, has emerged over the last two decades as an important lesion model for studying human semantic memory. Although it is well-known that semantic dementia is associated with temporal lobe degeneration, controversy remains over whether the semantic deficit is due to diffuse temporal lobe damage, damage to only a sub-region of the temporal lobe or even less severe damage elsewhere in the brain. The manner in which the right and left temporal lobes contribute to semantic knowledge is also not fully elucidated. In this study we used unbiased imaging analyses to correlate resting cerebral glucose metabolism and behavioural scores in tests of verbal and non-verbal semantic memory. In addition, a region of interest analysis was performed to evaluate the role of severely hypometabolic areas. The best, indeed the only, strong predictor of semantic scores across a set of 21 patients with frontotemporal lobar degeneration with semantic impairment was degree of hypometabolism in the anterior fusiform region subjacent to the head and body of the hippocampus. As hypometabolism in the patients’ rostral fusiform was even more extreme than the abnormality in other regions with putative semantic relevance, such as the temporal poles, the significant fusiform correlations cannot be attributed to floor-level function in these other regions. More detailed analysis demonstrated more selective correlations: left anterior fusiform function predicted performance on two expressive verbal tasks, whereas right anterior fusiform metabolism predicted performance on a non-verbal test of associative semantic knowledge. This pattern was further supported by an additional behavioural study performed on a wider cohort of patients with semantic dementia, in which the patients with more extensive right-temporal atrophy (when matched on degree of naming deficit to a set of cases with more extensive left temporal atrophy) were significantly more impaired on the test of non-verbal semantics. Our preferred interpretation of this laterality effect involves differential strength of connectivity between different regions of a widespread semantic network in the human brain.